E. coli Toxin Colibactin Emerges as Leading Suspect in Rising Bowel Cancer Among Under-50s

Colibactin E coli early onset bowel cancer, Digimart Global (United Kingdom): Exposure to a bacterial toxin in early life has emerged as a leading suspect in the rise of bowel cancer among people under 50, according to evidence given to the Commons science and technology committee. Cases of early onset bowel cancer have doubled in many countries over the past two decades, and while rising obesity and falling physical activity are contributors, researchers believe other factors must also be involved.

Dr Karl Smith-Byrne, a senior molecular epidemiologist at the University of Oxford, told the committee that known risk factors such as obesity, smoking and alcohol can explain only about half of the bowel cancer cases doctors diagnose. He said he did not find it plausible that the rise could be entirely explained by risks researchers already know about.

Last year, scientists identified colibactin, a toxin produced by some variants of E. coli bacteria in the gut, as a potential driver of early onset colorectal cancer.

Hallmark mutations caused by the toxin were three times more common in tumours from people under 40 than in those from people over 70. Smith-Byrne described colibactin as probably the leading explanation at the moment, but more work is needed to confirm whether it actually drives bowel cancer.

Research led by Prof Mike Stratton at the Sanger Institute, who was not at the hearing, has suggested that colibactin causes mutations in some children but not others, with mutations appearing as early as infancy. By the age of 10, affected children could have a similar mutational burden to a 50-year-old, his work showed.

Smith-Byrne, who is himself a survivor of early onset rectal cancer, said that if the toxin is causing mutations, it may give the colon or rectum a head start towards cancer at a sensitive stage of life.

Some researchers suspect that particular E. coli variants that normally live harmlessly in the gut have evolved in recent decades to produce colibactin.

Prof Elio Riboli, a cancer epidemiologist at Imperial College London, told the committee that colibactin is essentially found in people born after 1960, suggesting a change in the bacteria. Prof Helen Coleman, a cancer epidemiologist at Queen’s University Belfast, described colibactin as the first new clue in quite some time, while stressing that its role is still under investigation and may involve exposures in very early childhood or even the prenatal period.

Bowel cancer is the third most common cancer in the world, accounting for about one in 10 cases. The disease remains far more common in over-50s, but global figures suggest diagnoses are rising steeply in younger people.

Riboli said that while the unknown drivers of cancers must be uncovered, people should act on risks already clear: in the UK and US drinking and smoking are falling, but obesity is rising and physical activity is declining. He argued that about 60% of current cancers could be prevented by applying what is already known.

Freya Sullivan

Freya Sullivan covers British politics, parliamentary affairs, government policies, and economic developments. Her reporting explores major decisions, business trends, and public policy issues shaping the United Kingdom's political and economic landscape.

Leave a Reply

Your email address will not be published. Required fields are marked *

Sports

Explore Digimart Global